Pelargonium (Umcka): Benefits, Dosage, Forms & Research

What the Research Says

Pelargonium sidoides has an unusually strong evidence base for a herbal remedy. The Cochrane review by Timmer et al. (2013) analyzed 10 RCTs and concluded that EPs 7630 is effective and well-tolerated for acute bronchitis. Matthys et al. (2003) conducted a pivotal double-blind, placebo-controlled RCT showing significant reductions in bronchitis symptom severity scores after 7 days of treatment. The extract is approved as a licensed phytomedicine in Germany — a regulatory status that requires demonstration of efficacy and safety through clinical trials. The multi-target mechanism (antiviral, antibacterial, immunomodulatory, mucociliary) provides a pharmacological rationale for its clinical effectiveness.

Benefits of Pelargonium (Umcka)

• Bronchitis treatment — a Cochrane review by Timmer et al. (2013) of 10 RCTs found Pelargonium sidoides extract (EPs 7630) significantly reduced bronchitis symptom severity and duration compared to placebo, with good tolerability
• Antiviral mechanism — pelargonium extract interferes with viral hemagglutinin, preventing influenza and other respiratory viruses from attaching to and entering host cells. It also induces interferon production, enhancing antiviral defense
• Antibacterial adhesion inhibition — the prodelphinidins in pelargonium prevent bacteria from adhering to mucosal epithelial cells, reducing bacterial colonization and secondary infection risk during viral illness
• Immunomodulation — EPs 7630 stimulates macrophage phagocytic activity, enhances NK cell function, and increases production of pro-inflammatory cytokines (IL-1, IL-6, TNF-alpha) and interferon-beta
• Mucus clearance — pelargonium extract increases ciliary beat frequency in bronchial epithelium, improving mucociliary clearance and helping the body expel pathogens and mucus from the airways

Side Effects and Safety

Safety profile: Generally Safe

Potential Side Effects

• Generally well-tolerated in clinical trials
• Mild GI upset (stomach discomfort, nausea, heartburn) in some users
• Rare allergic reactions including skin rash
• Very rare hepatotoxicity cases reported — likely idiosyncratic; liver safety overall is reassuring in clinical trial data
• Rare gum bleeding reported

Drug & Supplement Interactions

• Anticoagulants — pelargonium may increase bleeding risk; use with caution if on warfarin or other blood thinners
• Immunosuppressants — pelargonium stimulates immune function; potential interaction with immunosuppressive therapy
• No other significant drug interactions identified in clinical studies